The effects of botox and voice therapy in the management of severe muscle tension dysphonia: A case study

Journal of Medical Speech-Language Pathology

Volumn 15, Issue 3, 2007, Pages 293-304

  Theodoros, Deborah ^a   Scudamore, Sallyanne ^a   Baldock, Patricia ^a   Coman, Scott ^b   Hancock, Kellie ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ACOUSTICS; ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DYSPHONIA; FEMALE; GLOTTIS; HUMAN; LARYNGOSCOPY; LARYNX; MUSCLE TONE; NOISE; PRIORITY JOURNAL; SPEECH; SPEECH THERAPY; TREATMENT OUTCOME; VIDEORECORDING; VOICE;

EID: 34948893003     PISSN: 10651438     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bassiouny S. (1998). Efficacy of the accent method of voice therapy. Folia Phoniatrica et Logopaedica, 50, 146-164.
2. Boone, D. R., & McFarlane, S. C. (2000). Voice disorders. In D. R. Boone & S. C. McFarlane (Eds.), The voice and voice therapy (6th ed., pp. 55-92). Boston: Allyn and Bacon.
3. Carding, P. N., & Horsley, I. A. (1992). An evaluation study of voice therapy in non-organic dysphonia. European Journal of Disorders of Communication, 27, 137-158.
4. Carding, P. N., Horsley, I. A., & Docherty, G. J. (1998). The effectiveness of voice therapy for patients with non-organic dysphonia. Clinical Otolaryngology, 23, 310-318.
5. Carding, P. N., Horsley, I. A., & Docherty, G. J. (1999). A study of the effectiveness of voice therapy in the treatment of 45 patients with nonorganic dysphonia. Journal of Voice, 13, 72-104.
6. Colton, R. H., & Casper, J. K. (1996). Voice misuse and abuse: Effects on laryngeal physiology. In R. H. Colton & J. K. Casper. Understanding voice problems: A Physiological perspective for diagnosis and treatment (2nd ed., pp. 78-141). Baltimore: Lippincott Williams & Wilkins.
7. Cooper, M. (1973). Voice disorders: Symptoms and causes. In M. Cooper (Ed.), Modern techniques of vocal rehabilitation (pp. 5-54). Springfield, IL: Charles C. Thomas.
8. Darley, F. L., Aronson, A. E., & Brown, J. R. (1975). Motor speech disorders. Philadelphia: W. B. Saunders.
9. Dejonckere, P. H. (1997, January). Histo-morphological study of the human ventricular fold: gender, age and topography related differences. Paper presented at: 26th Annual Symposium: Care of the Professional Voice, Philadelphia, PA. Cited by C. A. Rosen, & T. Murry (1999). Botox for hyperadduction of the false vocal folds: a case report. Journal of Voice, 13, 234-239.
10. Dworkin, J. P., Meleca, R. J., & Abkarian, G. (2000). Muscle tension dysphonia: Speech therapy and rehabilitation. Current Opinion in Otolaryngology and Head and Neck Surgery, 8, 169-173.
11. Dworkin, J. P., Meleca, R. J., Simpson, M. L., & Garfield, I. (2000). Use of topical lidocaine in the treatment of muscle tension dysphonia. Journal of Voice, 14, 567-574.
12. Eckel, F., & Boone, D. (1981). The s/z ratio as an indicator of laryngeal pathology. Journal of Speech and Hearing Disorders, 46, 147-149.
13. Eskenazi, L., Childers, D. G., & Hicks, D. M. (1990). Acoustic correlates of vocal quality. Journal of Speech and Hearing Research, 33, 298-306.
14. Feinstein, I., Hilger, P., Szachowicz, E., & Stimson, B. (1987). Laser therapy of dysphonia plica ventricularis. Annals of Otology, Rhinology and Laryngology, 96, 56-57.
15. Fex, B., Fex, S., Shiromoto, O., & Hirano, M. (1994). Acoustic analysis of functional dysphonia: Before and after voice therapy (accent method). Journal of Voice, 8, 163-167.
16. Jacobson, B. H., Johnson, A., Grywalski, C., Silbergleit, A., Jacobson, G., Benninger, M. S., et al. (1997). The voice handicap index (VHI): Development and validation. American Journal of Speech-Language Pathology, 6, 66-70.
17. Kay Elemetrics. (1993). Multi-dimensional voice program (MDVP). Pine Brook, NJ: Kay Elemetrics.
18. Kendall, K. A., & Leonard, R. J. (1997). Treatment of ventricular dysphonia with botulinum toxin. Laryngoscope, 10, 948-953.
19. Kent, R. D., Kent, J. F., & Rosenbek, J. C. (1987). Maximum performance tests of speech production. Journal of Speech and Hearing Disorders, 52, 367-387.
20. Kent, R. D., Vorperian, H. K., & Duffy, J. R. (1999). Reliability of the multi-dimensional voice program for the analysis of voice samples of subjects with dysarthria. American Journal of Speech- Language Pathology, 8, 129-136.
21. Kitch, J., Oates, J., & Greenwood, K. (1996). Performance effects on the voices of 10 choral tenors: Acoustic and perceptual findings. Journal of Voice, 10, 217-227.
22. Kotby, M. N. (1995). The accent method of voice therapy. San Diego: Singular Publishing Group.
23. Koufman, J. A., & Blalock, P. D. (1991). Functional voice disorders. Otolaryngologic Clinics of North America, 24, 1059-1073.
24. Maryn, Y., De Bodt, M. S., & Van Cauwenberge, P. (2003). Ventricular dysphonia: Clinical aspects and therapeutic options. Laryngoscope, 113, 859-866.
25. Mathieson, L. (2001). Hyperfunctional voice disorders. In L. Mathieson (Ed.), Greene and Mathieson's The voice and its disorders (6th ed., pp. 145-185). London: Whurr Publishers.
26. Mueller, P. B. (1971). Parkinson's disease: Motor speech behaviour in a selected group of patients. Folia Phoniatrica, 23, 333-346.
27. Oates, J. M. (1992). Perceptual evaluation of voice: Audiotape package. Melbourne, Australia: La Trobe University.
28. Oates, J., & Russell, A. (2003). A sound judgement. Melbourne, Australia: La Trobe University.
29. Pearson, E. J., & Sapienza, C. M. (2003). Historical approaches to the treatment of adductor spasmodic dysphonia. NeuroRehabilitation, 18, 325-338.
30. Reidenbach, M. M. (1998). The muscular tissue of the vestibular folds of the larynx. European Archives of Otorhinolaryngology, 255, 365-367.
31. Rosen, C. A., & Murry, T. (1999). Botox for hyperadduction of the false vocal folds: A case report. Journal of Voice, 13, 234-239.
32. Roy, N., Bless, D. M., Heisey, D., & Ford, C. N. (1997). Manual circumlaryngeal therapy for functional dysphonia: An evaluation of short- and long-term treatment outcomes. Journal of Voice, 11, 321-331.
33. Roy, N., Ford, C. N., & Bless, D. M. (1996). Muscle tension dysphonia and spasmodic dysphonia: The role of manual laryngeal tension reduction in diagnosis and management. Annals of Otology, Rhinology and Laryngology, 105, 851-856.
34. Simpson, L. L. (1992). Clinically relevant aspects of the mechanical action of botulinum neurotoxin. Journal of Voice, 6, 358-364.
35. Stone, R. E. (1983). Issues in clinical assessment of laryngeal function: Contraindications for subscribing to maximum phonation time and optimum fundamental frequency. In D. M. Bless, & J. H. Abbs (Eds.), Vocal fold physiology: Contemporary research and clinical issues (pp. 410-424). San Diego: College-Hill Press.
36. Von Doersten, P. G., Izdebski, K., Ross, J. C., & Cruz, R. M. (1992). Ventricular dysphonia: A profile of 40 cases. Laryngoscope, 102, 1296-1301.
37. Wolfe, V., Fitch, J., & Martin, D. (1997). Acoustic measures of dysphonic severity across and within voice types. Folia Phoniatrica Logopaedica, 49, 292-299.